Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Rask Hamm

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Internal Medicine|July 8, 2021
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 primingCecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, et al.
Journal of Neuroimmunology|October 5, 2023
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravisSonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, et al.
The British Journal of Dermatology|January 26, 2023
Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort studyAmanda Kvist-Hansen, Laura Pérez-Alós, Rownaq Fares Al-Sofi, et al.
European Journal of Haematology|May 8, 2023
Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignanciesLine Dam Heftdal, Sebastian Rask Hamm, Laura Pérez-Alós, et al.
AIDS (London, England)|December 23, 2024
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetesLouise Bering, Line Dam Heftdal, Safura-Luise Heidari, et al.
Frontiers in Immunology|March 14, 2022
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy ControlsSebastian Rask Hamm, Dina Leth Møller, Laura Pérez-Alós, et al.
Nature Communications|March 29, 2022
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factorsLaura Pérez-Alós, Jose Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Frontiers in Immunology|January 30, 2023
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infectionOmid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, et al.
BMJ Open Respiratory Research|July 6, 2022
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseasesZitta Barrella Harboe, Sebastian Rask Hamm, Laura Pérez-Alós, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Internal Medicine|July 8, 2021
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 primingCecilie Bo Hansen, Ida Jarlhelt, Rasmus Bo Hasselbalch, et al.
Journal of Neuroimmunology|October 5, 2023
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravisSonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, et al.
The British Journal of Dermatology|January 26, 2023
Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort studyAmanda Kvist-Hansen, Laura Pérez-Alós, Rownaq Fares Al-Sofi, et al.
European Journal of Haematology|May 8, 2023
Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignanciesLine Dam Heftdal, Sebastian Rask Hamm, Laura Pérez-Alós, et al.
AIDS (London, England)|December 23, 2024
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetesLouise Bering, Line Dam Heftdal, Safura-Luise Heidari, et al.
Frontiers in Immunology|March 14, 2022
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy ControlsSebastian Rask Hamm, Dina Leth Møller, Laura Pérez-Alós, et al.
Nature Communications|March 29, 2022
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factorsLaura Pérez-Alós, Jose Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Frontiers in Immunology|January 30, 2023
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infectionOmid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, et al.
BMJ Open Respiratory Research|July 6, 2022
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseasesZitta Barrella Harboe, Sebastian Rask Hamm, Laura Pérez-Alós, et al.
Pageof 3